ESCRT-0 complex modulates Rbf-mutant cell survival by regulating Rhomboid endosomal trafficking and EGFR signaling

Area of Science:

• Cell Biology
• Genetics
• Cancer Research

Background:

• The Retinoblastoma (Rb) tumor suppressor is crucial for cell cycle regulation.
• Rb inactivation can lead to uncontrolled cell proliferation or apoptosis.
• Identifying synthetic lethal interactions with Rb mutations can reveal therapeutic targets.

Purpose of the Study:

• To identify genes that are synthetically lethal with fly Rb (rbf) mutations.
• To understand the mechanisms by which ESCRT-0 components affect Rb-mutant cell survival.
• To explore the role of ESCRT-0 in EGFR signaling pathways.

Main Methods:

• Conducted a genetic screen in Drosophila to identify synthetic lethal interactions.
• Utilized mutations in fly Rb (rbf) and ESCRT-0 components (stam and hrs).
• Analyzed EGFR signaling, Hid protein levels, and Rhomboid trafficking using endosomal markers (Rab5 and Rab7).

Main Results:

• Identified synthetic lethal interactions between rbf and ESCRT-0 components stam and hrs.
• Demonstrated that ESCRT-0 inactivation sensitizes rbf-mutant cells to apoptosis.
• Showed that ESCRT-0 mutants inhibit EGFR signaling by disrupting Rhomboid endosomal trafficking.
• Observed accumulation of Rhomboid protein in abnormal endosomes in stam mutants.

Conclusions:

• ESCRT-0 inactivation promotes apoptosis in Rb-mutant cells via EGFR signaling inhibition.
• Disruption of Rhomboid trafficking by ESCRT-0 mutants impacts EGFR signaling in ligand-producing cells.
• Loss of ESCRT-0 function has complex effects on EGFR signaling, potentially increasing or decreasing it.